| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Attovia Therapeutics, Inc.
13G
ATTO · 04987L102
|
9.2% |
11/16/2026
Event 9/30/2026
|
||||
| venBio Global Strategic Fund IV, L.P. | 9.2% | |||||
| venBio Global Strategic GP IV, LLC | 9.2% | |||||
|
Alumis Inc.
13G/A
ALMS · 022307102
|
4.8% |
11/17/2025
Event 6/30/2025
|
||||
| venBio Global Strategic Fund IV, L.P. | 4.8% | |||||
| venBio Global Strategic GP IV, LLC | 4.8% | |||||
| Adelman Robert J | 4.8% | |||||
| Goodman Corey S | 4.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.